Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(92 intermediate revisions by 6 users not shown)
Line 4: Line 4:
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned (Target Page Completion Date)'''!!'''Associate Editor'''
!'''Date Assigned to Author'''
!Author Content Pending or Complete (Date Completed)
!'''Target Completion Date'''
!Editor Reviewed (Date)
!'''Author Content (Pending or Complete)'''
!Notes
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|PENDING
|
|
|
|
Line 18: Line 22:
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
Line 26: Line 32:
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 34: Line 42:
|    Polycythaemia Vera  (PV)||Disease
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|Gokce A. Toruner
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 42: Line 52:
|    Primary Myelofibrosis  (PMF)||Disease
|    Primary Myelofibrosis  (PMF)||Disease
|T. Niroshi  Senaratne
|T. Niroshi  Senaratne
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|8/4/2020 before submission
|
|
|
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith (trainee) + faculty TBD
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|complete/pending faculty review
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Mark Evans (trainee), Fabiola Quintero-Rivera
|(trainee), Daynna J.Wolff
|
|
|pending faculty review
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
|Thomas Lee
|8/17/2020
|9/7/2020
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''||
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|complete
| ||FQR
| ||FQR
|
|
|
|
|
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung
|Thuy Phung/Shuo-Shawn Liu
|
|
|complete/pending adding content online as of 2/4/21
|
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 88: Line 110:
|    Systemic Mastocytosis||Disease
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|Shashi Shetty
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung
|Thuy Phung +Jordan Lowery
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
Line 140: Line 176:
|Disease
|Disease
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 149: Line 187:
|Disease
|Disease
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 157: Line 197:
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|FQR
|
|Complete
|Complete
|
|FQR
|
|
|
|
|-
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|9/1/20
|PENDING
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|9/1/20
|pending
|
|
|FQR
|FQR
|
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|9/1/20
|PENDING
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|complete
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
| || ||
| || ||
|
|
|
| ||
| ||
|
|
|
|
|
Line 268: Line 340:
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|Complete
|Complete
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|
|-
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|03/01/2021-MS (re-review)
|
|
|
|-
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
| ||JH / MS
|PENDING
|
|
|
|PENDING
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|PENDING
|03/01/2021-MS
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
| ||JH / MS
|
|PENDING
|
|Complete
|02/03/2021||JH / MS
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|PENDING
|03/02/2021-MS
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|03/02/2021-MS (re-review)
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|04/26/2021 -MS (re-review)
|
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|
|
|JH / MS
|
|Complete
|Complete
|
|
|JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
| ||JH / MS
|Complete
|
|
|
|Complete
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|-
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|03/01/2021-MS (re-review)
|
|
|
|-
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|03/01/2021-MS (re-review)
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|03/01/2021-MS (re-review)
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|02/24/2021-MS (re-review)
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|Need permission for figure?  Update WHO?
|Need permission for figure?  Update WHO?
|-
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
| ||JH / MS
|
|Complete
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|Add WHO reference
|Add WHO reference
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|Check reference format
|Check reference format
|-
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|Need permission for figure?
|Need permission for figure?
|-
|-
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|Check reference format
|Check reference format
|-
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|Check reference format
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
| ||JH / MS
|Complete
|
|
|
|
|-
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease||
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|
|
|PENDING
| ||JH / MS
| ||JH / MS
|??
|
|
|
|
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|
|
|PENDING
| ||JH / MS
| ||JH / MS
|??
|
|
|
|
Line 541: Line 703:
|Disease
|Disease
|Kay Weng Choy + Greg Conboy (Monash Health)
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
|
|
|JH / MS
|JH / MS
|Complete
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 550: Line 714:
|Disease
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|PENDING
|
|
|JH / MS
|JH / MS
|PENDING
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 559: Line 725:
|Disease
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|PENDING
|
|
|JH / MS
|JH / MS
|PENDING
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
| || ||
|
|
|
| ||
| ||
|
|
|
|
|
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Yassmine Akkari (YA)
| ||Yassmine Akkari (YA)
|
|
|
|
|
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|
|
|
| ||YA
| ||YA
|
|
|
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|
|-
|PENDING
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||
| ||YA
| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|PENDING
|
|
|YA
|YA
|PENDING
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|
|-
|PENDING
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||
| ||YA
| ||YA
|
|
|
|
|
Line 611: Line 793:


Lisa Smith + Yassmine Akkari
Lisa Smith + Yassmine Akkari
|
|
|Complete
|
|
|YA
|YA
|Complete
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|
|
|-
|PENDING
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
| ||YA
| ||YA
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|Complete
|
|
|YA
|YA
|Complete
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
| ||YA
|
|
|
|
|
|PENDING
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
| ||YA
| ||YA
|
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
| ||YA
|
|
|
|
|
|PENDING
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
| ||YA
| ||YA
|
|
|
|
|-
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
| ||YA
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Disease
|Helene Bruyere
|Celeste Eno
|
|
|
|YA
|PENDING
|PENDING
|
|YA
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
| ||
|Disease
|Marilena Melas
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
| ||Snehal Patel (SP)
|Disease
|Chenkai Ma
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|SP
|PENDING
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|SP
|PENDING
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|
|SP
|PENDING
|PENDING
| ||YA
|
|
|
|
|-
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|SP
|Complete
|
|
|Malini to review
|PENDING
|-
| ||YA
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|SP
|Complete
|
|
|Malini to review
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|SP
|Complete
|
|
|Malini to review
|PENDING
|-
| ||YA
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|SP
|Complete
|
|
|Malini to review
|-
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
| || ||
|
|
|SP
|Complete
|
|
|Malini to review
|-
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|
|
|SP
| ||
|PENDING
|
|
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|SP
| ||Snehal Patel (SP)
|PENDING
|
|
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
| ||SP
|
|
|
|
|
|
|
|-
|SP
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
|-
|-
|    Mu Heavy Chain Disease||Disease||
|       Monoclonal B-cell Lymphocytosis||Disease||
| ||SP
|
|
|
|
|
|
|-
|   Gamma Heavy Chain  Disease||Disease||
| ||SP
|
|
|SP
|
|
|
|
|-
|-
|    Alpha Heavy Chain  Disease||Disease||
|B-cell Prolymphocytic Leukemia||Disease||
| ||SP
|
|
|
|
|
|
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|SP
|SP
|PENDING
|
|
|
|
|-
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|
|SP
|SP
|PENDING
|
|
|
|
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|Complete
|
|
|SP
|SP
|PENDING
|
|
|
|
|-
|-
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|Complete
|
|
|SP
|SP
|PENDING
|
|
|
|
|-
|-
|    Plasmacytoma||Disease||Zhenya Tang
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|
|SP
|SP
|PENDING
|
|
|
|
|-
|-
|'''''    Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
| ||SP
|
|
|
|
|Complete
|
|
|-
|SP
|           Primary  Amyloidosis||Disease||
| ||SP
|
|
|
|
|
|-
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|Lymphoplasmacytic Lymphoma||Disease||
| ||SP
|
|
|
|
|
|
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
| ||SP
|
|
|SP
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease||
|   Waldenstrom  Macroglobulinemia||Disease||
| ||SP
|
|
|
|
|
|
|-
|         TEMPI Syndrome||Disease||
| ||SP
|
|
|SP
|
|
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|SP
|PENDING
|
|
|
|
|-
|Nodal Marginal Zone Lymphoma||Disease||
| ||SP
| ||SP
|
|
|
|
|
|-
|-
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|SP
|PENDING
|
|
|
|
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|SP
| ||SP
|PENDING
|
|
|
|
|-
|-
|    Testicular Follicular Lymphoma||Disease||Ruthann Pfau
|    Mu Heavy Chain Disease||Disease||
|
|
|SP
|PENDING
|
|
|
|
|-
| ||SP
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|SP
|PENDING
|
|
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|
|
|-
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|SP
|Complete
|PENDING
|5/26/2021||SP
|
|
|
|
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|    Alpha Heavy Chain  Disease||Disease||
|
|
|SP
|PENDING
|
|
|
|
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||
| ||SP
| ||SP
|
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
| ||SP
|
|
|
|
|
|PENDING
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|SP
|SP
|PENDING - due 8/15/20
|
|
|
|
|-
|-
|    Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|PENDING
|
|
|SP
|SP
|PENDING - due 8/31/20
|
|
|
|
|-
|-
|    In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|PENDING
|
|
|SP
|SP
|PENDING - due 8/15/20
|
|
|
|
|-
|-
| || ||
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
| ||
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|
|Greg Corboy (GC)
|PENDING
|PENDING
|
|SP
|
|
|
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
| ||GC
|
|
|
|
|
|
|-
| ||SP
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
| ||GC
|
|
|
|-
|           Primary  Amyloidosis||Disease||
|
|
|
|
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
| ||GC
|
|
| ||SP
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|           Light Chain and Heavy Chain Deposition Disease||Disease||
| ||GC
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
| ||GC
|
|
|
|
|
|
|-
| ||SP
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
| ||GC
|
|
|
|
|
|-
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|         POEMS Syndrome||Disease||
| ||GC
|
|
|
|
|
|
|-
| ||SP
|Lymphomatoid Granulomatosis||Disease||
| ||GC
|
|
|
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|         TEMPI Syndrome||Disease||
| ||GC
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
| ||GC
|3/9/21
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease||
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
| ||GC
|
|
|
|
|
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
| ||GC
|Complete
|Complete
|5/28/2021||SP
|
|
|
|
|-
|-
|Primary Effusion Lymphoma||Disease||
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
| ||GC
|
|
|
|Complete
|11/11/2020
|SP
|
|
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|Follicular Lymphoma||Disease||Ruthann Pfau
| ||GC
|
|
|
|
|PENDING
|
|
|-
|SP
|   Multicentric Castleman  Disease||Disease||
| ||GC
|
|
|
|
|
|-
|-
|   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|    Testicular Follicular Lymphoma||Disease||Ruthann Pfau
| ||GC
|
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|   HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||
|    In Situ Follicular Neoplasia||Disease||Ruthann Pfau
| ||GC
|
|
|
|
|PENDING
|
|
|-
|SP
|Burkitt Lymphoma||Disease||
| ||GC
|
|
|
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
| ||GC
|
|
|
|
|PENDING
|
|
|-
|SP
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
| ||GC
|
|
|
|
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
| ||GC
|
|
|Complete
|8/16/2020
|SP
|
|
|
|
|-
|-
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
| ||GC
|
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
| ||GC
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
| || ||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
| ||
|
|8/15/20
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
| ||Snehal Patel (SP)
|
|
|
|
|
|
|
|-
|SP
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
| ||SP
|PENDING
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|    In Situ Mantle Cell  Neoplasia||Disease||
| ||SP
|PENDING
|
|
|
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
| ||SP
|PENDING
|
|
|
|
|-
|Aggressive NK-cell Leukemia||Disease||
| ||SP
|
|
|SP
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
| || ||
| ||SP
|
|
|
|
| ||
|
|
|
|
|-
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
| ||SP
|
|
|
|
|PENDING
|
|
|-
|Greg Corboy (GC)
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
| ||SP
|
|
|
|
|
|-
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
|
|-
| ||GC
|    Severe Mosquito Bite  Allergy||Disease||
| ||SP
|
|
|
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
| ||SP
|
|
|
|
|
|
|-
| ||GC
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
| ||SP
|
|
|
|
|
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|SP
|
|PENDING
|
| ||GC
|
|
|
|
|-
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|
|
|SP
|PENDING
|
|
|
|
|-
| ||GC
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|SP
|PENDING
|
|
|
|
|-
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|SP
|PENDING
|
|
|
|
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|SP
| ||GC
|PENDING
|
|
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
| ||SP
|PENDING
|
|
|
|
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
| ||SP
|
|
| ||GC
|
|
|
|
|-
|-
|Mycosis Fungoides||Disease||
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
|
|-
| ||GC
|Sézary Syndrome||Disease||
| ||SP
|
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|Lymphomatoid Granulomatosis||Disease||
| ||SP
|
|
|
|
|
|
|-
| ||GC
|    Lymphomatoid  Papulosis||Disease||
| ||SP
|
|
|
|
|
|-
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
|
|-
| ||GC
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
| ||SP
|
|
|
|
|
|-
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|Intravascular Large B-cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
|
|-
| ||GC
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
|-
|-
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|ALK-Positive Large B-cell Lymphoma||Disease||
| ||SP
|
|
|
|
|
|
|-
| ||GC
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
| ||SP
|
|
|
|
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
| ||SP
|
|
|Complete
| ||GC
|
|
|
|
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|Primary Effusion Lymphoma||Disease||
| ||SP
|
|
|
|
|
|
|-
| ||GC
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|SP
|PENDING
|
|
|
|
|-
|-
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|SP
|PENDING
|
|
|
|
|-
| ||GC
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||
| ||SP
|
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|   Multicentric Castleman  Disease||Disease||
|
|
|SP
|
|PENDING
|
| ||GC
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|SP
| ||GC
|PENDING
|
|
|
|
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|SP
|PENDING
|
|
|
|
|-
| ||GC
| || ||
| ||
|
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
| ||Associate Editor??
|3/11/21
|
|
|PENDING
| ||GC
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
| ||
|
|
|
|
|
|
|-
| ||GC
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
| ||
|
|
|
|
|
|-
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
| ||
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
| ||
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
| ||
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|    Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease||
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
| ||
|
|
|
|
|
|
|-
| ||GC
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
| ||
|
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease||
| || ||
| ||
|
|
|
|
|
|
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
| ||
| ||
|
|
|
|
|
|-
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
| ||
|
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
 
Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|
|
|
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
| ||
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|          Monomorphic  B-cell PTLD||Disease||
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
| ||
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|Aggressive NK-cell Leukemia||Disease||
| ||
|
|
|
|
|
|
|-
| ||SP
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
| ||
|
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''||
| ||
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
| ||
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease||
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
| ||
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
| ||
|
|
|
|
|
|
|-
| ||SP
|   Langerhans Cell  Histiocytosis||Disease||
| ||
|
|
|
|
|
|-
|-
|   Langerhans Cell Sarcoma||Disease||
|    Severe Mosquito Bite Allergy||Disease||
| ||
|
|
|
|
|
|
|-
| ||SP
|Indeterminate Dendritic Cell Tumour||Disease||
| ||
|
|
|
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|Adult T-cell Leukemia/Lymphoma||Disease||
| ||
|
|
|
|
|
|
|-
| ||SP
|Follicular Dendritic Cell Sarcoma||Disease||
| ||
|
|
|
|
|
|-
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
| ||
|
|
|
|
|
|
|-
| ||SP
|Fibroblastic Reticular Cell Tumor||Disease||
| ||
|
|
|
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
| ||
|
|
|
|
|PENDING
|
|
|-
|SP
|Erdheim-Chester Disease||Disease||
| ||
|
|
|
|
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|-
| || ||
| ||
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
| || ||
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
| ||
|
|
|
|
|PENDING
|
|
|-
|SP
| || ||
| ||
|
|
|
|
|
|-
|-
| || ||
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
| ||
|
|
|
|
|PENDING
|
|
|-
|SP
| || ||
| ||
|
|
|
|
|
|-
|-
| || ||
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
| ||
|
|
|
|
|PENDING
|
|
|-
|SP
| || ||
| ||
|
|
|
|
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|-
| || ||
| ||
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
| || ||
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
| ||
|
|
|
|
| ||SP
|
|
|
|
|-
|-
| || ||
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
| ||
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
| || ||
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
| ||
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
| || ||
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
| ||
|
|
|
|
|
|
|-
| ||SP
| || ||
| ||
|
|
|
|
|
|-
|-
| || ||
|    Lymphomatoid  Papulosis||Disease||
| ||
|
|
|
|
|
|
|-
| ||SP
| || ||
| ||
|
|
|
|
|
|-
|-
| || ||
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
| ||
|
|
|
|
|
|
|-
| ||SP
| || ||
| ||
|
|
|
|
|
|-
|-
| || ||
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
| ||
|
|
|
|
|
|
|-
| ||SP
| || ||
| ||
|
|
|
|
|
|-
|-
| || ||
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
| ||
|
|
|
|
|
|
|}
| ||SP
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Associate Editor'''
!Author Content
(Pending or Complete)
!Editor Reviewed (Date)
!Notes
|-
|BCR
|Brian Davis
|
|
|Complete (8/10/18)
|
|
|-
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|-
|ABL1
|Brian Davis
|
|
|Complete (4/16/19)
|
| ||SP
|
|
|
|
|-
|-
|RUNX1
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|Brian Davis
|
|
|Complete (6/9/19)
|
|
|
|
|-
| ||SP
|RUNX1T1
|Brian Davis
|
|Complete (5/23/19)
|
|
|
|
|-
|-
|MYH11
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|Brian Davis
|
|
|Complete (8/6/18)
|
|
|
|
|-
| ||SP
|FLT3
|Kay Weng Choy
|
|Complete (
|
|
|
|
|-
|-
|NPM1
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|Kay Weng Choy
|
|
|Complete (
|
|
|
|
|-
| ||SP
|TP53
|Kay Weng Choy
|
|Complete (
|
|
|
|
|-
|-
|DNMT3A
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|Kay Weng Choy
|
|
|Complete (
|
|
|
|
|-
| ||SP
|CEBPA
|Gordana
|
|Complete (
|
|
|
|
|-
|-
|IDH1
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|Paul De Fazio
|
|
|Complete (
|
|
|PENDING
|
|
|-
|SP
|IDH2
|Paul De Fazio
|
|Complete (
|
|
|
|
|-
|-
|PML
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|Brian Davis
|
|
|Complete (12/5/18)
|
|
|PENDING
|
|
|-
|SP
|RARA
|Brian Davis
|
|
|Complete (8/3/18)
|
|
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|-
|ETV6
|Brian Davis
|
|
|Complete (6/9/19)
|PENDING
| ||SP
|
|
|
|
|-
|-
|KIT
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|Brian Davis
|
|
|Complete (10/1/18)
|
|
|PENDING
|
|
|-
|SP
|CBFB
|Brian Davis
|
|Complete (8/2/18)
|
|
|
|
|-
|-
|GATA2
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|Kay Weng Choy
|
|
|Complete (
|
|
|PENDING
|
|
|-
|SP
|PTEN
|Beth Pitel
|
|Pending
|
|
|
|
|-
|-
|MLTT3
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|MECOM
| || ||
|Brian Davis
|
|
|Pending
|
|
|
|
|-
| ||
|FGFR1(FLT2)
|Brian Davis
|
|Pending
|
|
|
|
|-
|-
|KMT2A
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Greg Corboy (GC)
|
|
|
|
|-
|-
|DEK
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|NUP214
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|RBM15
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|MKL1
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|DDX41
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|ANKRD26
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|CUX1
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|TET2
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|EZH2
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|FOXP1
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|MYC
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|
|
|GC
|
|
|
|
|-
|-
|JAK2
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|WT1
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|CBL
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|NF1
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|SUZ12
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|ERG
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|EST2
|Histiocytic Sarcoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|RPS14
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|RB1
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|MPL
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|CHGA
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|CDH1
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|SRSF2
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
|
|
| ||GC
|
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease||
|DNMT1
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|PRDX2
| || ||
|
|
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|-
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|-
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|-
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|-
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|-
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|-
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|-
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|-
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|-
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|PTEN
|Beth Pitel
|
|
|Pending
|
|
|
|
|-
|MLTT3
|
|
|
|
|
|
|
|
|-
|MECOM
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|FGFR1(FLT2)
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|KMT2A
|
|
|
|
|
|
|
|
|-
|DEK
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|NUP214
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|RBM15
|
|
|
|
|
|
|
|
|-
|MKL1
|
|
|
|
|
|
|
|
|-
|DDX41
|Ying Zou
|8/7/20
|
|Pending
|
|
|
|
|-
|ANKRD26
|
|
|
|
|
|
|
|
|-
|CUX1
|
|
|
|
|
|
|
|
|-
|TET2
|
|
|
|
|
|
|
|
|-
|EZH2
|
|
|
|
|
|
|
|
|-
|FOXP1
|
|
|
|
|
|
|
|
|-
|MYC
|
|
|
|
|
|
|
|
|-
|JAK2
|
|
|
|
|
|
|
|
|-
|WT1
|DONE
|
|
|DONE
|
|
|
|
|-
|CBL
|
|
|
|
|
|
|
|
|-
|NF1
|
|
|
|
|
|
|
|
|-
|SUZ12
|
|
|
|
|
|
|
|
|-
|ERG
|
|
|
|
|
|
|
|
|-
|EST2
|
|
|
|
|
|
|
|
|-
|RPS14
|
|
|
|
|
|
|
|
|-
|RB1
|
|
|
|
|
|
|
|
|-
|MPL
|
|
|
|
|
|
|
|
|-
|CHGA
|
|
|
|
|
|
|
|
|-
|CDH1
|
|
|
|
|
|
|
|
|-
|SRSF2
|
|
|
|
|
|
|
|
|-
|DNMT1
|
|
|
|
|
|
|
|
|-
|PRDX2
|
|
|
|
|
|
|
|
|-
|ASXL1
|DONE
|
|
|DONE
|
|
|
|
|-
|MN1
|
|
|
|
|
|
|
|
|-
|SF3A1
|
|
|
|
|
|
|
|
|-
|EP300
|
|
|
|
|
|
|
|
|-
|JARID2
|
|
|
|
|
|
|-
|ASXL1
|
|
|
|
Line 1,998: Line 2,756:
|
|
|-
|-
|MN1
|BRCA1
|
|
|
|
|
|
|
|
|-
|SF3A1
|
|
|
|
Line 2,012: Line 2,766:
|
|
|-
|-
|EP300
|BRCA2
|
|
|
|
|
|
|
|
|-
|JARID2
|
|
|
|
Line 2,029: Line 2,779:
|
|
|
|
|
|
|
|-
|
|
|
|
Line 2,043: Line 2,789:
|
|
|
|
|
|
|
|-
|
|
|
|
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"